News - Reproductive, Mylan Laboratories

Filter

Popular Filters

Watson gets FDA final approval for generic Actos; negative news on Prochieve appeal

29-10-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) said on Friday that it has launched a generic…

ActosDiabetesGenericsLegalMylan LaboratoriesNorth AmericaProchieveRegulationReproductiveTakeda PharmaceuticalsWatson Pharmaceuticals

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA

02-12-2011

US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by…

CaduetCardio-vascularGeneress FeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPfizerReproductiveWarner ChilcottWomen's Health

Mylan settles with Novartis over Vivelle-Dot; Impax files for generic Fentora

21-11-2011

US generics drugmaker Mylan (Nasdaq: MYL) says it has settled a patent litigation law suit with the US…

CephalonCIMA LabsFentoraGenericsImpax LaboratoriesMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulationReproductiveVivelle-Dot

Back to top